Wilms‘ tumor 1 peptide-loaded dendritic cell vaccination in patients with relapsed or refractory malignant lymphoma 2022-02-15/in Dendritic Cells, International Publications, Malignant Lymphoma /von 2022-02-15 / Leuk Lymphoma 2022 Jul;63(7):1733-1737 PMID: 35166650 Journal: Leukemia & lymphoma (volume: 63, issue: 7, Leuk Lymphoma 2022 Jul;63(7):1733-1737) Published: 2022-02-15 Authors: Ogasawara M, Miyashita M, Yamagishi Y, Ota S ABSTRACT Open in PubMed https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg 0 0 2022-02-15 / Leuk Lymphoma 2022 Jul;63(7):1733-1737 https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg 2022-02-15 / Leuk Lymphoma 2022 Jul;63(7):1733-17372022-02-15 00:00:002022-02-15 00:00:00Wilms' tumor 1 peptide-loaded dendritic cell vaccination in patients with relapsed or refractory malignant lymphoma
